dc.contributor.author | Smith, Timothy Andrew Davies | |
dc.contributor.author | Simpson, Michael | |
dc.contributor.author | Cheyne, Richard William | |
dc.contributor.author | Trembleau, Laurent Alain Claude | |
dc.date.accessioned | 2013-03-01T12:45:00Z | |
dc.date.available | 2013-03-01T12:45:00Z | |
dc.date.issued | 2011-10 | |
dc.identifier.citation | Smith , T A D , Simpson , M , Cheyne , R W & Trembleau , L A C 2011 , ' 18F-PEG-biotin : Precursor (boroaryl-PEG-biotin) synthesis, 18F-labelling and an in-vitro assessment of its binding to NeutravidinTM -trastuzumab pre-treated cells ' , Applied Radiation and Isotopes , vol. 69 , no. 10 , pp. 1395-1400 . https://doi.org/10.1016/j.apradiso.2011.05.005 | en |
dc.identifier.issn | 0969-8043 | |
dc.identifier.other | PURE: 4539350 | |
dc.identifier.other | PURE UUID: 410fa3fc-cc46-460c-9b34-602ec1c47491 | |
dc.identifier.other | Scopus: 79960958959 | |
dc.identifier.other | ORCID: /0000-0001-6376-9077/work/72631845 | |
dc.identifier.uri | http://hdl.handle.net/2164/2684 | |
dc.format.extent | 6 | |
dc.language.iso | eng | |
dc.relation.ispartof | Applied Radiation and Isotopes | en |
dc.rights | NOTICE: this is the author’s version of a work that was accepted for publication in Applied Radiation and Isotopes. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Applied Radiation and Isotopes, [VOL 69, ISSUE 10, (2011)] DOI: 10.1016/j.apradiso.2011.05.005 | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | 18F | en |
dc.subject | PET | en |
dc.subject | Neutravidin™ | en |
dc.subject | breast cancer cells | en |
dc.subject | Biotin | en |
dc.subject | QD Chemistry | en |
dc.subject.lcc | QD | en |
dc.title | 18F-PEG-biotin : Precursor (boroaryl-PEG-biotin) synthesis, 18F-labelling and an in-vitro assessment of its binding to NeutravidinTM -trastuzumab pre-treated cells | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Preprint | en |
dc.identifier.doi | https://doi.org/10.1016/j.apradiso.2011.05.005 | |